Novo Nordisk’s weekly insulin Awiqli wins US approval, offering alternative to daily diabetes injections

Unlike injectable diabetes drugs such as Ozempic and Mounjaro, which help lower blood sugar by mimicking hormones that regulate appetite and insulin release, Awiqli is an insulin replacement therapy designed for people who require basal insulin The post Novo Nordisk’s weekly insulin Awiqli wins US approval, offering alternative to daily diabetes injections appeared first on Arabian Business: Latest News on the Middle East, Real Estate, Finance, and More .

Go to News Site